Pfizer Inc. (NYSE: PFE) Stock News & Analysis
Pfizer Inc. (NYSE: PFE) is a healthcare company, listed on the NYSE. Alpha Stocks Insight has published 1 article on PFE since Tuesday, August 4, 2026, most recently "Pfizer (NYSE: PFE) Q2 2026: $4.3B Impairment Masks Adjusted EPS Beat, Guidance Raised" on Tuesday, August 4, 2026. Coverage to date spans Earnings Report, tracking PFE's earnings, analyst activity, and material corporate events. New coverage is added each trading day.
PFE Coverage -- 1 Article
Pfizer (NYSE: PFE) Q2 2026: $4.3B Impairment Masks Adjusted EPS Beat, Guidance Raised
Adjusted EPS of $0.77 beat the $0.69 estimate by 11.4%, but $4.3B in non-cash impairments drove a GAAP loss of $0.04 per share. Full-year revenue guidance raised to $60.5B-$62.5B.
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.